HDT Bio Corp.

About HDT Bio Corp.

HDT Bio is a clinical-stage private biotechnology company focused on developing advanced products to treat and prevent cancer and infectious diseases. They leverage the body's immune system with a transformative therapeutic platform, utilizing their proprietary LION™ technology to ensure superior safety, potency, durability, and manufacturing advantages.

Products & Services

LION™ Technology:A proprietary technology that increases potency, safety, tolerability, immunogenicity, and manufacturability compared to traditional formulations, used in products for cancer and infectious diseases.

HDT-321:A first-in-class product for the prevention of deadly tick-borne disease, recently approved by the FDA.

repRNA/LION™ Technology for Malaria Vaccine:Licensed to MalarVx for the development of a novel malaria vaccine using self-amplifying replicon RNA (repRNA) and LION™ platform.

Single-RNA Vaccine for Enterovirus-D68:A vaccine under development against enterovirus-D68, as detailed in a Science Direct publication.

Specialties

Cancer therapeutics Infectious disease prevention Immune-enhancing solutions Biodefense Oncology Vaccine development LION™ technology Self-amplifying replicon RNA (repRNA)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Award T: - FT: Award	A: 1000000 MR: - FA: $1 million FAN: 1000000	D: 2023-10-04 FD: 2023-10-04	2 investors

Award Latest

2023-10-04

$1.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Adam Dunko

Director, Quality

LinkedIn (Pro only)

A

Allie Lafferty

Research Associate I

A

Alyse Douglass

Research Associate III

A

Alyssa Camp

Director, Grants Management

A

Amit Khandhar

Director, Formulations

A

Andre Lieber

Scientific Co-Founder

View 53 more team members with Pro

Unlock Full Team Directory

Recent News

HDT Bio Corp. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised